Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Medical Oncology
•
Breast Cancer, Metastatic
What is your experience and treatment efficacy of tucatinib if used after enhertu in metastatic breast cancer?
Related Questions
How do you treat front line de novo HER2 positive metastatic breast cancer with brain metastases?
In a patient with BRCA2 mutation and contralateral axillary recurrence of ER+ IDC with an ESR1 CCDC170 fusion on NGS testing, would you use standard adjuvant AI therapy or consider adjuvant SERD therapy (fulvestrant/elacestrant)?
In a patient with hormone-positive early breast cancer who experienced a myocardial infarction (MI) while on aromatase inhibitors (AI), should tamoxifen be considered as an alternative treatment?
Is there any data to use PIK3CA directed agents in mutated metastatic triple negative breast cancer?
Is there benefit of cold-cap use while patient is on sacituzumab-govitecan?
What are your top takeaways in Breast Cancer from ESMO 2024?
How do you monitor blood glucose levels in patients without preexisting diabetes who are starting capivasertib?
What are your top takeaways in Medical Oncology from SABCS 2024?
How would you approach a patient with metastatic high grade neuroendocrine carcinoma of the breast which is HR+ HER2 negative?
What is the current paradigm for breast cancer diagnosed with isolated metastases prior to initial treatment?
